BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond) 2020;40:301-12. [PMID: 32558385 DOI: 10.1002/cac2.12067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Yu HY, Jin YL. Metastatic low-grade endometrial stromal sarcoma with variable morphologies in the ovaries and mesentery: A case report. World J Clin Cases 2022; 10(23): 8384-8391 [DOI: 10.12998/wjcc.v10.i23.8384] [Reference Citation Analysis]
2 Xu T, Yu D, Zhou W, Yu L. A nomogram model for the risk prediction of type 2 diabetes in healthy eastern China residents: a 14-year retrospective cohort study from 15,166 participants. EPMA Journal. [DOI: 10.1007/s13167-022-00295-0] [Reference Citation Analysis]
3 Ma C, Peng S, Zhu B, Li S, Tan X, Gu Y. The nomogram for the prediction of overall survival in patients with metastatic lung adenocarcinoma undergoing primary site surgery: A retrospective population-based study. Front Oncol 2022;12:916498. [DOI: 10.3389/fonc.2022.916498] [Reference Citation Analysis]
4 Deng P, Xu K, Zhou X, Xiang Y, Xu Q, Sun Q, Li Y, Yu H, Wu X, Yan X, Guo J, Tang B, Liu Z. Constructing prediction models for excessive daytime sleepiness by nomogram and machine learning: A large Chinese multicenter cohort study. Front Aging Neurosci 2022;14:938071. [DOI: 10.3389/fnagi.2022.938071] [Reference Citation Analysis]
5 Cao S, Liao X, Xu K, Xiao H, Shi Z, Zou Y, Li C, Hu Y, Yan S. Development and validation of tumor-size-stratified prognostic nomograms for patients with uterine sarcoma: A SEER database analysis. Cancer Med 2022. [PMID: 35841316 DOI: 10.1002/cam4.5014] [Reference Citation Analysis]
6 Zhang Z, Zhanghuang C, Wang J, Mi T, Liu J, Tian X, Jin L, He D. A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients Undergoing Surgery With Prostate Cancer: A Population-Based Study. Front Public Health 2022;10:935521. [DOI: 10.3389/fpubh.2022.935521] [Reference Citation Analysis]
7 Geng R, Song J, Zhong Z, Ni S, Liu W, He Z, Gan S, Huang Q, Yu H, Bai J, Liu J. Crosstalk of Redox-Related Subtypes, Establishment of a Prognostic Model and Immune Responses in Endometrial Carcinoma. Cancers 2022;14:3383. [DOI: 10.3390/cancers14143383] [Reference Citation Analysis]
8 Yang W, Yang L, Huang Y, Wang T, Sun X, Tong X, Liu W, Yin Y, Tao K, Zhang P. Diagnostic accuracy of C-reactive protein and procalcitonin in the early diagnosis of infections after laparoscopic rectal cancer surgery. ANZ J Surg 2022. [PMID: 35818676 DOI: 10.1111/ans.17895] [Reference Citation Analysis]
9 Chen Y, Zhao W, Bi F, Pan X, Yin L, Zhao C, Adnan M. Significance of TP53 Mutational Status-Associated Signature in the Progression and Prognosis of Endometrial Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-18. [DOI: 10.1155/2022/1817339] [Reference Citation Analysis]
10 He Y, Zhang Y, Chong W, Pei Y, Zhang R, Liu Z, Yu J, Peng X, Fang F. Association of Underweight and Weight Loss With Poor Prognosis and Poor Therapy Effectiveness in Brain Metastases: A Retrospective Study. Front Nutr 2022;9:851629. [DOI: 10.3389/fnut.2022.851629] [Reference Citation Analysis]
11 Borella F, Bertero L, Cassoni P, Piovano E, Gallio N, Preti M, Cosma S, Ferraioli D, Pace L, Mariani L, Biglia N, Benedetto C. Low-Grade Uterine Endometrial Stromal Sarcoma: Prognostic Analysis of Clinico-Pathological Characteristics, Surgical Management, and Adjuvant Treatments. Experience From Two Referral Centers. Front Oncol 2022;12:883344. [DOI: 10.3389/fonc.2022.883344] [Reference Citation Analysis]
12 Kang Y, Zuo Y, He M, Duo L, Chen X, Tang W. Clinical predictive model to estimate probability of remission in patients with lupus nephritis. Int Immunopharmacol 2022;110:108966. [PMID: 35764016 DOI: 10.1016/j.intimp.2022.108966] [Reference Citation Analysis]
13 Zhu K, Chen Y, Guo R, Dai L, Wang J, Tang Y, Zhou S, Chen D, Huang S. Prognostic Factor Analysis and Model Construction of Triple-Negative Metaplastic Breast Carcinoma After Surgery. Front Oncol 2022;12:924342. [DOI: 10.3389/fonc.2022.924342] [Reference Citation Analysis]
14 Zhang W, Ji L, Zhong X, Zhu S, Zhang Y, Ge M, Kang Y, Bi Q. Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study. Front Public Health 2022;10:884349. [PMID: 35712294 DOI: 10.3389/fpubh.2022.884349] [Reference Citation Analysis]
15 Lu Z, He W, Zhou J, Yang C, Xiang R. Construction and validation of a novel prognostic nomogram for patients with metastatic renal cell carcinoma: a SEER-based study. J Int Med Res 2022;50:3000605221105367. [PMID: 35726570 DOI: 10.1177/03000605221105367] [Reference Citation Analysis]
16 Zhang S, Song W, Yang B, Jia H, Chen S, Li J, Yang C. A non-invasive model based on the virtual portal pressure gradient to predict the first variceal hemorrhage in cirrhotic patients. Hepatol Int 2022. [PMID: 35585289 DOI: 10.1007/s12072-022-10344-5] [Reference Citation Analysis]
17 Gu L, Xia Z, Qing B, Chen H, Wang W, Chen Y, Yuan Y. The Core Role of Neutrophil–Lymphocyte Ratio to Predict All-Cause and Cardiovascular Mortality: A Research of the 2005–2014 National Health and Nutrition Examination Survey. Front Cardiovasc Med 2022;9:847998. [DOI: 10.3389/fcvm.2022.847998] [Reference Citation Analysis]
18 Hu Q, Hong X, Xu L, Jia R. A nomogram for accurately predicting the pathological upgrading of prostate cancer, based on 68 Ga-PSMA PET/CT. Prostate 2022. [PMID: 35468221 DOI: 10.1002/pros.24358] [Reference Citation Analysis]
19 Zhu H, Zhao S, Zhao T, Jiang K, Miao L, Jiang M, Wang F. Development and validation of prognostic nomograms for patients with metastatic small bowel adenocarcinoma: a retrospective cohort study. Sci Rep 2022;12:5983. [PMID: 35396531 DOI: 10.1038/s41598-022-09986-0] [Reference Citation Analysis]
20 Liu X, Lin E, Sun Y, Liu X, Li Z, Jiao X, Li Y, Guo D, Zhang P, Feng X, Chen T, Niu Z, Zhou Z, Qiu H, Zhou Y. Postoperative Adjuvant Imatinib Therapy-Associated Nomogram to Predict Overall Survival of Gastrointestinal Stromal Tumor. Front Med 2022;9:777181. [DOI: 10.3389/fmed.2022.777181] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Weng J, Chen L, Liu H, Yang X, Huang L. Ferroptosis Markers Predict the Survival, Immune Infiltration, and Ibrutinib Resistance of Diffuse Large B cell Lymphoma. Inflammation. [DOI: 10.1007/s10753-021-01609-6] [Reference Citation Analysis]
22 Liu P, Kuang Y, Ye L, Peng C, Chen W, Shen M, Zhang M, Zhu W, Lv C, Chen X. Predicting the Risk of Psoriatic Arthritis in Plaque Psoriasis Patients: Development and Assessment of a New Predictive Nomogram. Front Immunol 2022;12:740968. [DOI: 10.3389/fimmu.2021.740968] [Reference Citation Analysis]
23 Qi Y, Wu S, Tao L, Xu G, Chen J, Feng Z, Lu C, Wan Y, Li J. A Population-Based Study: How to Identify High-Risk T1-2 Esophageal Cancer Patients? Front Oncol 2021;11:766181. [PMID: 34966675 DOI: 10.3389/fonc.2021.766181] [Reference Citation Analysis]
24 Zhou X, Qiu S, Jin K, Yuan Q, Jin D, Zhang Z, Zheng X, Li J, Wei Q, Yang L. Predicting Cancer-Specific Survival Among Patients With Prostate Cancer After Radical Prostatectomy Based on the Competing Risk Model: Population-Based Study. Front Surg 2021;8:770169. [PMID: 34901145 DOI: 10.3389/fsurg.2021.770169] [Reference Citation Analysis]
25 Liu YY, Xu BS, Pan QZ, Weng DS, Zhang X, Peng RQ. New nomograms to predict overall and cancer-specific survival of angiosarcoma. Cancer Med 2022;11:74-85. [PMID: 34786885 DOI: 10.1002/cam4.4425] [Reference Citation Analysis]
26 Shen H, Deng G, Chen Q, Qian J. The incidence, risk factors and predictive nomograms for early death of lung cancer with synchronous brain metastasis: a retrospective study in the SEER database. BMC Cancer 2021;21:825. [PMID: 34271858 DOI: 10.1186/s12885-021-08490-4] [Reference Citation Analysis]
27 Dai Q, Xu B, Wu H, You Y, Wu M, Li L. The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort study. Orphanet J Rare Dis 2021;16:160. [PMID: 33827628 DOI: 10.1186/s13023-021-01802-8] [Reference Citation Analysis]
28 Wu J, Zhang H, Li L, Hu M, Chen L, Wu S, Xu B, Song Q. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis. Int J Gynecol Cancer 2020;30:1520-7. [PMID: 32839227 DOI: 10.1136/ijgc-2020-001409] [Reference Citation Analysis]
29 Wu J, Zhang H, Li L, Hu M, Chen L, Xu B, Song Q. A nomogram for predicting overall survival in patients with low-grade endometrial stromal sarcoma: A population-based analysis. Cancer Commun (Lond) 2020;40:301-12. [PMID: 32558385 DOI: 10.1002/cac2.12067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]